Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Isocitrate dehydrogenase and related oxidative decarboxylases.

Literature DB >> 6774891

Isocitrate dehydrogenase and related oxidative decarboxylases.

K Dalziel.

Abstract

Mesh：

Substances：

Year: 1980 PMID： 6774891 DOI： 10.1016/0014-5793(80)80569-2

Source DB: PubMed Journal: FEBS Lett ISSN： 0014-5793 Impact factor: 4.124

Keyword Cloud
Cited

× No keyword cloud information.

15 in total

1. Characterizing Lysine Acetylation of Isocitrate Dehydrogenase in Escherichia coli.

Authors: Sumana Venkat; Hao Chen; Alleigh Stahman; Denver Hudson; Paige McGuire; Qinglei Gan; Chenguang Fan
Journal: J Mol Biol Date: 2018-05-04 Impact factor: 5.469

Review 2. Neomorphic mutations create therapeutic challenges in cancer.

Authors: V Takiar; C K M Ip; M Gao; G B Mills; L W T Cheung
Journal: Oncogene Date: 2016-11-14 Impact factor: 9.867

3. Pigeon liver malic enzyme.

Authors: R Y Hsu
Journal: Mol Cell Biochem Date: 1982-03-05 Impact factor: 3.396

4. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Authors: Andrea E Calvert; Alexandra Chalastanis; Yongfei Wu; Lisa A Hurley; Fotini M Kouri; Yingtao Bi; Maureen Kachman; Jasmine L May; Elizabeth Bartom; Youjia Hua; Rama K Mishra; Gary E Schiltz; Oleksii Dubrovskyi; Andrew P Mazar; Marcus E Peter; Hongwu Zheng; C David James; Charles F Burant; Navdeep S Chandel; Ramana V Davuluri; Craig Horbinski; Alexander H Stegh
Journal: Cell Rep Date: 2017-05-30 Impact factor: 9.423

Review 5. Metabolic interactions with cancer epigenetics.

Authors: Xia Gao; Michael A Reid; Mei Kong; Jason W Locasale
Journal: Mol Aspects Med Date: 2016-09-09

Review 6. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

Authors: Inga-Marie Schaefer; Jason L Hornick; Judith V M G Bovée
Journal: Lab Invest Date: 2018-01-16 Impact factor: 5.662

Isocitrate dehydrogenase and related oxidative decarboxylases.

1. Characterizing Lysine Acetylation of Isocitrate Dehydrogenase in Escherichia coli.

Review 2. Neomorphic mutations create therapeutic challenges in cancer.

3. Pigeon liver malic enzyme.

4. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation.

Review 5. Metabolic interactions with cancer epigenetics.

Review 6. The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.

7. Mechanisms involved in the functional divergence of duplicated GroEL chaperonins in Myxococcus xanthus DK1622.

8. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.

9. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.

Review 10. What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer.